Evidence map›Paper›PMID 34072520›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Chitosan Nanoparticles as a Promising Nanomaterial for Encapsulation of Pomegranate (

Maral Soltanzadeh, Seyed Hadi Peighambardoust, Babak Ghanbarzadeh, Maryam Mohammadi, José M Lorenzo

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Chitosan-Loaded Inorganic Oxide Nanocomposites (SiOFoods (Basel, Switzerland) · 2026
    Article
  7. Enhanced Antioxidant and Anti-bacterial Potential ofCurrent medicinal chemistry · 2026
    Article
  8. Chitosan Nanoparticles Loaded withPlants (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Review
  11. FeACS omega · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Impacts ofToxicology research · 2025
    Article
  16. Nanoencapsulation of Asparagus (Food science & nutrition · 2025
    Article
  17. Article
  18. Review
  19. Chitosan Nanoparticle-EncapsulatedInternational journal of molecular sciences · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maral SoltanzadehDepartment of Food Science, College of Agriculture, University of Tabriz, Tabriz 5166616471, Iran.ORCID 0000-0002-5487-7102
Seyed Hadi PeighambardoustDepartment of Food Science, College of Agriculture, University of Tabriz, Tabriz 5166616471, Iran.ORCID 0000-0002-8438-7315
Babak GhanbarzadehDepartment of Food Science, College of Agriculture, University of Tabriz, Tabriz 5166616471, Iran.
Maryam MohammadiDepartment of Food Science, College of Agriculture, University of Tabriz, Tabriz 5166616471, Iran.
José M LorenzoCentro Tecnológico de la Carne de Galicia, Rúa Galicia N°4, Parque Tecnológico de Galicia, San Cibrao das Viñas, 32900 Ourense, Spain.ORCID 0000-0002-7725-9294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The encapsulation of pomegranate peel extract (PPE) in chitosan nanoparticles (CSNPs) is an advantageous strategy to protect sensitive constituents of the extract. This study was aimed to develop PPE-loaded CSNPs and characterize their physical, structural morphology, antioxidant and antimicrobial properties. Spherical NPs were successfully synthesized with a mean diameter of 174-898 nm, a zeta potential (ZP) of +3-+36 mV, an encapsulation efficiency (EE) of 26-70%, and a loading capacity (LC) of 14-21% depending on their loaded extract concentrations. Based on these results, CSNPs with chitosan:PPE ratio of 1:0.50 (

Indexed as

bioactive compoundsnanocarriernanostructureparticlespomegranate peelproperties

Identifiers

PMID34072520
PMCPMC8228277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.